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ABSTRACT 
Cancer classification has been one of the most challenging tasks in 
clinical diagnosis.  At present cancer classification is done mainly 
by looking through the cells’ morphological differences, which do 
not always give a clear distinction of cancer subtypes. 
Unfortunately, this may have a significant impact on the final 
outcome of whether a patient could be cured effectively.   
Microarray technology can play an important role on diagnosing 
which type of disease one is carrying. The gene selection process is 
critical for developing gene markers for faster and more accurate 
diagnosis. In this paper, we develop a method using pairwise data 
comparisons instead of the one-over-the-rest approach used 
nowadays. Results are evaluated using available clustering 
techniques including hierarchical clustering and k-means clustering. 
Using pairwise comparison, the best accuracy achieved is 95% 
while it is only 83% when using one-over-the-rest approach.
1. INTRODUCTION 
Instead of classifying cancers based on microscopic histology and 
tumor morphology, the introduction of microarray technology 
significantly improves the discovery rates of different types of 
cancers through monitoring thousands of gene expressions in a 
parallel, rapid and efficient manner. Several studies have been 
successful [1-4] in differentiating various cancer cell-types.  
Genes present in different cells in our human body are 
responsible for carrying out unique functions at their specific 
locations. The problem is out of the 25,000 genes present in the 
human genome, how we can identify something representative of 
the brain [5] is a great challenge. The answer lies in the essence of 
genes selection. Gene expression patterns are useful for 
classification, diagnosis and understanding of diseases [6]. In the 
case of classifying microarray data which often contains far more 
genes than samples, we need to first select a small set of 
informative genes that can effectively discriminate samples into 
different classes. While most of the test-statistics are developed for 
the use of two classes, in the case of multiple classes which we are 
focusing on, we propose a gene selection procedure based on 
pairwise testing, although the one-versus-the-rest testing procedure 
is most often employed instead. The accuracy is greatly improved 
when using pairwise testing for we use all possible combinations 
of groups available in the dataset. Details of the two gene selection 
algorithms will be presented in the following section.  
2. DATASET AND METHODS 
2.1. Descriptions on Dataset 
Brain cancer is chosen as a test case. Little is known about the 
biology of brain cancer and quite often there is controversy on 
diagnosis solely based on the cells’ morphological differences. 
Classifications till now are based on the tumors’ originalities (cell 
types) but not their locations. Tumors can develop in any types of 
cells, and that’s why classification of brain cancer is so difficult [7]. 
A number of genes that may be involved in glial tumorigenesis [8] 
and in prediction of glioblastoma survival [9] have been identified 
recently. The dataset we use is obtained from the website [10] 
which contains 92 brain cancer samples grouped into 5 classes.
2.2. Two-group comparison approaches - pairwise versus 
one-over-the-rest algorithm
Our approach to select genes is to rank them by their 
discrimination power and select those that are most discriminative. 
Signal-to-noise score (SNR) is chosen both as our statistic and also 
in the paper. The conventional one-versus-the-rest multiple 
comparison method compares each data subgroup with the rest of 
the data and selects representative genes for each subgroup, as in 
[11-12]. To illustrate this, we have 5 groups of samples (g1-g5). 
Five comparisons are made: g1 versus g2-g5; g2 versus g1, g3-g5; 
g3 versus g1-g2, g4-g5; g4 versus g1-g3, g5; and g5 versus g1-g4.  
10 genes are selected from each comparison so we have 50 in total 
[2, 10]. The problem with this approach is that it cannot find genes 
that have dissimilar expression profiles between the single group 
and each of the groups in the other group. Here we propose an 
alternative approach using pairwise testing. The proposed method 
involves using SNR across the pairs of groups one by one. SNR is 
performed between any two groups. Using the same illustration, 
representative genes on g1 can be found by running the SNR 
between g1 and g2 first. 5 genes, which attain the largest p-values 
out of all, are selected.  Similarly, this SNR is run between g1 and 
each of the remaining groups (i.e. between g1 and g3; g1 and g4; 
g1 and g5). As a result, 20 genes altogether are selected to 
represent the group g1. After iterative computation, 50 different 
genes are selected for all five groups.  
3. RESULTS  
A total of 50 genes are selected using each of the two methods 
described in Section 2. Verification on whether the selected genes
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 can be used to properly classify the samples is done by clustering. 
Hierarchical and k-means clustering are chosen.  
3.1. Hierarchical clustering results comparison 
   
Fig. 1a. (Left) Hierarchical clustering on genes selected by one-over-the-
rest method; Fig. 1b. (Right) Hierarchical clustering on genes selected by 
pairwise comparison method. 
As shown from Fig. 1a, rows represent samples and columns 
represent genes. Very little difference can be observed across the 
expression levels of the genes selected by the one-versus-the-rest 
multiple comparison method, by which only 76 out of 92 samples 
are classified correctly into the 5 groups. Fig. 1b shows that the 
genes selected by our pairwise SNR method give much better 
differentiation of the samples from different classes. Using our 
pairwise method, only 4 samples are misclassified. 
3.2. k-means clustering results comparison  
Fig. 2a. (Left) k-means clustering on genes selected by one-over-the-rest 
method; Fig. 2b. (Right) k-means clustering on genes selected by pairwise 
comparison method. 
Results of k-means clustering are shown in Fig. 2. Samples are 
grouped in priori to their predefined groups before doing clustering. 
The x-axis represents the sample identification number while y-
axis represents the defined group (numbered 1 to 5). Using the 
one-versus-the-rest multiple comparison method, only 65 out of 92 
samples are classified correctly into the 5 groups. In Fig. 2b, 72 of 
them are classified accordingly using pairwise approach. 
Results of the two clustering techniques applied to the 
expressions of genes selected by the one-versus-the-rest and the 
pairwise testing methods are summarized in Table 1.
Table 1. Summary on accuracies of different clustering algorithms based 
on two comparison methods 
 one-versus-the-rest  pairwise 
Hierarchical clustering 83% 95% 
k-means clustering  71% 78% 
4. DISCUSSIONS & CONCLUSIONS 
Accuracy of pathological diagnoses on patients can be improved 
by the technique of microarray analysis. No doubt gene selection 
process lies in the heart of this technique. The results given in 
Table 1 show that our proposed pairwise comparison approach 
used in multiple classes classification outperforms the original one-
over-the-rest method irrespective of whether classification is 
performed using hierarchical or k-means clustering. Genes cluster 
together are those with common expression profiles which means 
they may share regulatory pathways, and further studies into these 
may clarify the mechanisms of this common co-regulation [13]. 
Unknown gene functions and regulations can then be inferred more 
efficiently using standard molecular approaches. 
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